source
- Avenzo Therapeutics to go public via reverse merger with Rallybio after Candid partnership endsOn June 1, 2026, Avenzo Therapeutics announced that it will become a publicly traded company through a reverse merger with Rallybio, securing a Nasdaq listing after its previous partner, Candid, en…
- Turn Therapeutics reports faster symptom relief in Phase 2 eczema trialTurn Therapeutics, a California biotech, disclosed interim results from its Phase 2 study of a topical treatment for atopic dermatitis. The analysis of 50 patients indicated that skin symptoms imp…